https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00011-6/fulltext
0
0
1/12/23 at 11:34pm
Organization
The Lancet
Authors
If the COVID-19 pandemic has a silver lining, it is the development within a year
of a novel mRNA vaccine against the causative virus, SARS-CoV-2. Now a new partnership
aims to turn the lessons learned from this scientific achievement into treatment advances
…
Create an account
or login to join the discussion